Wallace Advisory Group LLC Has $859,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Wallace Advisory Group LLC trimmed its position in Zoetis Inc. (NYSE:ZTS) by 1.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,395 shares of the company’s stock after selling 81 shares during the quarter. Wallace Advisory Group LLC’s holdings in Zoetis were worth $859,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ZTS. Webster Bank N. A. raised its holdings in shares of Zoetis by 89.1% during the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock worth $29,000 after buying an additional 82 shares in the last quarter. Quarry LP lifted its holdings in shares of Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares during the last quarter. Neo Ivy Capital Management acquired a new stake in shares of Zoetis in the 4th quarter valued at approximately $40,000. LRI Investments LLC bought a new stake in shares of Zoetis during the 1st quarter valued at approximately $43,000. Finally, Hazlett Burt & Watson Inc. grew its holdings in shares of Zoetis by 60.7% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 270 shares of the company’s stock valued at $46,000 after purchasing an additional 102 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Piper Sandler upped their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. BTIG Research lifted their price target on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus upped their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Finally, Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Zoetis has a consensus rating of “Buy” and an average target price of $220.38.

Zoetis Trading Down 0.5 %

Shares of NYSE:ZTS traded down $0.96 during trading on Friday, reaching $190.03. The stock had a trading volume of 1,697,760 shares, compared to its average volume of 2,576,563. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm’s fifty day moving average is $187.30 and its 200 day moving average is $175.45. The stock has a market cap of $86.09 billion, a price-to-earnings ratio of 36.61, a P/E/G ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. The business had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.41 earnings per share. As a group, equities analysts forecast that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.